Vesugen: Reference Overview and Reconstitution Notes

Vesugen is a short, man-made peptide (a tiny chain of amino acids, the building blocks that make up proteins) known by the abbreviation KED (Lys-Glu-Asp). It belongs to the Khavinson family of research compounds. It is supplied for laboratory research only and is not approved by the FDA.

Vesugen

What it is

Vesugen is a short, man-made peptide. A peptide is a tiny chain of amino acids (the building blocks that make up proteins). This one has just three amino acids: Lysine, Glutamic acid, and Aspartic acid. Together they are shortened to KED (Lys-Glu-Asp). Vesugen belongs to the Khavinson family of peptides, a group developed through aging research in Russia.

It falls in the same "ultrashort peptide" group as Epitalon, Pinealon, and similar Khavinson compounds. This article is a neutral reference covering what Vesugen is, its research status, and basic lab handling.

Research context and categorization

Vesugen is classed as a Khavinson bioregulator (a type of small peptide thought to influence how body tissues behave). Within that group, it is described as the vascular-focused member. Vascular means related to blood vessels. Research on Vesugen often focuses on the endothelium (the thin layer of cells that lines the inside of blood vessels) and topics linked to blood vessel aging.

Proposed Mechanisms

The Khavinson research group proposes that these tiny peptides attach to DNA at specific spots and change which genes get switched on or off. Think of DNA as a recipe book and these peptides as bookmarks that tell the cell which recipes to follow. Based on this idea, Vesugen has been studied in lab experiments looking at how blood vessel cells work, how vessels widen or narrow (called vascular tone), and signs linked to blood vessel aging.

These ideas are still being investigated. Most of the research comes from one group, and other scientists have not widely confirmed the findings yet. The way Vesugen works and what it does are not proven or approved. It should be seen as a research compound, not a treatment with known benefits.

Key point: Vesugen is an investigational research compound with limited independent confirmation. Its proposed vascular mechanisms are not clinically confirmed or approved.

Status

• Regulatory status: Research only. Vesugen is not FDA-approved and has no approved use in humans or animals. It is sold as a research chemical. Independent confirmation of its effects, outside the original research group, is limited.
• Sport status: Vesugen is not listed by name on the WADA Prohibited List. (WADA is the World Anti-Doping Agency, which sets the rules for substance use in sport.) However, because it has no approval from any government health authority for human use, it falls under the WADA S0 category ("non-approved substances"). Athletes who follow the WADA Code should treat it as prohibited.

Reconstitution notes (general)

Vesugen usually comes as a lyophilized (freeze-dried) powder. Lyophilized means the liquid was removed to keep the compound stable, similar to the way instant coffee is made. Before lab use, you add liquid to bring it back into solution. This step is called reconstitution. The liquid used is bacteriostatic water, a purified water with a small amount of preservative that stops bacteria from growing. The concentration you get equals the milligrams of peptide in the vial divided by the milliliters of water you add.

For example, a 20 mg vial mixed with 3 mL of bacteriostatic water gives about 6.7 mg/mL. The same vial mixed with 2 mL gives 10 mg/mL. Use the peptide calculator to work out the concentration for your vial.

Dilution and handling notes (compound-specific)

Vesugen arrives as a freeze-dried powder, so you mix it with liquid before use rather than using it straight from the vial. Vials are commonly sold in the 20 mg size. Most researchers add between 2 mL and 3 mL of bacteriostatic water. That puts the working concentration in roughly the 6.7 mg/mL to 10 mg/mL range, depending on how much water you use.

KED is a very small peptide. Its three amino acids (lysine, glutamic acid, and aspartic acid) have a strong attraction to water, a property called being hydrophilic (water-loving). This makes KED highly water-soluble, meaning it dissolves easily in water. It does not dissolve well in oily or non-water-based solvents. Water-based liquids (called aqueous diluents) are the standard choice for mixing.

Reconstitution Steps

1. Temperature prep: Let the sealed vial and the water warm to room temperature before you start. This helps prevent temporary cloudiness that can appear when cold liquid hits the powder.
2. Add diluent: Add the water slowly along the inside wall of the vial. Do not squirt it directly onto the powder.
3. Dissolve: Let the vial stand, then swirl it gently. Do not shake it hard. Hard shaking causes foaming, which can damage the peptide where air meets liquid. A gentle swirl is enough. The powder usually clears within a minute or two, without heating or a vortex mixer.

Unlike some larger or oilier peptides, KED does not usually turn thick, stringy, or form a solid when mixed at these concentrations. So if you see cloudiness or floating particles after mixing, something is wrong. Possible causes include contamination, damaged material, or the wrong type of liquid. A properly mixed solution should look clear and colorless.

Handling and storage

• Temperature: Store the mixed vial in the refrigerator at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit) and keep it away from light.
• Hygiene & Tracking: Wipe the rubber stopper with an alcohol swab before each puncture. Write the date you mixed the vial on a label and attach it to the vial.
• Lifespan: Use the mixed vial within about 4 weeks while refrigerated. Throw it away if it turns cloudy, changes color, or has visible particles floating in it.

Related reading

• VIP (Vasoactive Intestinal Peptide)
• 5-Amino-1MQ
• Adamax
• How Reconstitution Works
• How Long Does a Reconstituted Vial Last?

Tools and supplies

• peptide calculator
• Bacteriostatic Water 30 ml
• Gansulin Metal Reusable Pen
• 3 ml Glass Cartridges (10-pack)
• Complete Starter Kit

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.

Frequently asked questions

What is Vesugen peptide?

Vesugen (KED) is a three-amino-acid ultrashort peptide belonging to the Khavinson family of research compounds, proposed to target vascular endothelium in laboratory studies.

What is the regulatory status of Vesugen?

Vesugen is a research-only compound not FDA-approved for any human or animal use, falling under WADA S0 as a non-approved substance.

How is Vesugen supplied and reconstituted?

Vesugen comes as a lyophilized freeze-dried powder and is reconstituted by adding bacteriostatic water to achieve the desired concentration for lab use.

What the research community gets wrong about Vesugen

• "Vesugen" and "KED" are treated as two different things. They are the same molecule. Vesugen is a trade name for the tripeptide Lys-Glu-Asp, which the scientific literature almost always calls KED. When you search databases, use the sequence (Lys-Glu-Asp) or the PubChem entry, not the brand name, or you will miss most of the real records.
• The gene-regulation mechanism gets stated as settled fact. The idea that these short peptides enter the cell nucleus and bind DNA to change which genes are active comes mostly from one research group. Independent labs have not widely reproduced it. Treat it as a proposed mechanism still under study, not a proven one.
• People assume "ultrashort" means "hard to ruin." KED is very small and water-loving, so it dissolves quickly, but a reconstituted vial is still open to microbial contamination and slow breakdown once it sits in solution. Clean technique, cold and dark storage, and a written mix date still matter at the bench.
• The "vascular" label gets confused with vascular medicines. Vesugen is described as the vessel-focused member of its peptide series, but that is a research description, not evidence that it behaves like an approved blood-vessel drug. It is a research compound with limited independent data.
• mg/mL gets mistaken for the amount of molecules. KED has a small molecular weight (about 390 g/mol). A given mg/mL of KED holds far more molecules than the same mg/mL of a larger peptide. If you compare compounds by mass alone, you can misjudge how much material you are actually handling.

From our bench: If you reconstitute a KED vial, we would like your real numbers. Record your vial size in milligrams, the exact volume and type of water you added, the temperature of the vial and the water, and time the mix with a stopwatch until the solution looks fully clear and colorless. Note whether any faint cloudiness appeared and then cleared on its own. Share your measured values (we will not fill in any numbers for you) so other researchers can compare their results against yours.

Sources

1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
4. PubChem CID 87571363, Lysyl-glutamyl-aspartic acid (Lys-Glu-Asp / KED), molecular formula C15H26N4O8
5. Ashapkin V, Khavinson V, et al. Gene expression in human mesenchymal stem cell aging cultures: modulation by short peptides (studies KED/Lys-Glu-Asp). Mol Biol Rep. 2020;47(6):4323-4329. PMID 32399807
6. Khavinson VK, Popovich IG, Linkova NS, et al. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053. PMID 34834147